Advanced Search
TANG Liu Ying, DENG Yi Lan, LUO Can, QIAO Ya Ping, ZHU Ying Xian. Research progress on intervention strategies for mother-to-child transmission of hepatitis B[J]. CHINESE JOURNAL OF WOMEN AND CHILDREN HEALTH, 2021, 12(4): 84-88,93. DOI: 10.19757/j.cnki.issn1674-7763.2021.04.018
Citation: TANG Liu Ying, DENG Yi Lan, LUO Can, QIAO Ya Ping, ZHU Ying Xian. Research progress on intervention strategies for mother-to-child transmission of hepatitis B[J]. CHINESE JOURNAL OF WOMEN AND CHILDREN HEALTH, 2021, 12(4): 84-88,93. DOI: 10.19757/j.cnki.issn1674-7763.2021.04.018
shu

Research progress on intervention strategies for mother-to-child transmission of hepatitis B

  • 1. Guangdong Maternal and Child Health Care Hospital, Guangzhou 511442, Guangdong Province, China;

  • 2. School of Public Health, Guangzhou Medical University, Guangzhou 511436, Guangdong Province, China;

  • 3. SINOVAC BIOTECH CO., LTD., Beijing 100085, China

More Information
  • Received Date: July 26, 2020
  • Available Online: January 12, 2023
    Graphical Abstract
    • Abstract
  • Hepatitis B virus(HBV) infection is a major public health problem worldwide,which threatens physical and mental health of patients seriesly. China is high prevalence area of HBV,and pregnant women are generally susceptible. Mother-to-child transmission(MTCT) is the main route for children to be infected with HBV in their early stage. Comprehensive intervention of preventing MTCT of HBV deserves to pay more attention. Through literature reviews,this paper summarized the intervention strategies and their effects of preventing MTCT of HBV in order to provide evidence for improving comprehensive approaches to the prevention and treatment of MTCT of HBV in China.
    • FullText(HTML)
    • References (58)
  • [1]
    贾辅忠,李兰娟.感染病学[M].南京:凤凰出版传媒集团江苏科学技术出版社,2010:157.
    [2]
    Ashish K. Hepatitis B virus infection and pregnancy:a practical approach[J]. Indian Journal of Gastroenterology,2012,31(2):43-54.
    [3]
    Centers for Disease Control and Prevention(CDC). Assessing Completeness of Perinatal Hepatitis B Virus Infection Reporting Through Comparison of Immunization Program and Surveillance Data-United States[J].MMWR,2011,60(13):410-413.
    [4]
    WHO. New hepatitis data highlight need for urgent global response[EB/OL]. https:∥www. who. int/zh/newsroom/detail/21-04-2017-new-hepatitis-data-highlightneed-for-urgent-global-response. 2017-4-21/2020-3-20.
    [5]
    WHO. Global hepatitis report,2017[EB/OL]. https:∥www. who. int/hiv/pub/hepatitis/global-hepatitis-report2017-executive-summary/zh/.2017-4/2020-3-20
    [6]
    思广慧,付婷,师玉卓,等.乙型病毒性肝炎的预后研究进展[J].中华老年多器官疾病杂志,2019,18(9):709-712.
    [7]
    崔富强,庄辉.中国实施新生儿乙型肝炎母婴阻断的策略和建议[J].中国病毒病杂志,2019,9(5):1-6.
    [8]
    Ozaras R,Inanc B,Yemisen M,et al. Epidemiology of HBV subgenotypes D[J]. Clin Res Hepatol Gastroenterol,2015,39(1):28-37.
    [9]
    张国民,缪宁,郑徽,等.中国2005—2016年乙型病毒性肝炎报告发病的年龄和地区特征[J].中国疫苗和免疫,2018,24(2):121-126.
    [10]
    Zhang S,Wang F,Zhang Z. Current advances in the elimination of hepatitis B in China by 2030[J]. Front Med,2017,11(4):490-501.
    [11]
    Ding C,Fu X,Zhou Y,et al. Disease burden of liver cancer in China from 1997 to 2016:an observational study based on the Global Burden of Diseases[J]. BMJ Open,2019. 3(6):383-403.
    [12]
    Zhang W,Ji Z,Wang L,et al. A meta-analysis of HBs Ag-positive rate among general Chinese populations aged 1-59 years[J]. Infect Dis,2015,47(12):878-888.
    [13]
    Polaris Observatory Collaborators. Global prevalence,treatment,and prevention of hepatitis B virus infection in 2016:a modelling study[J]. Lancet Gastroenterol Hepatol,2018,3(6):383-403.
    [14]
    蔡承业,孙爱武,郑徽.甲型乙型肝炎联合疫苗临床研究进展[J].中国疫苗和免疫,2019,25(2):233-237.
    [15]
    王贵强,王福生,庄辉,等.慢性乙型肝炎防治指南(2019年版)[J].临床肝胆病杂志,2019,35(12):2648-2669.
    [16]
    刘娜,徐光华,曾庆磊,等.乙型肝炎病毒传播途径研究[J].肝脏,2011,16(4):343-344.
    [17]
    杨杰,陈超.新生儿保健学[M].北京:人民卫生出版社,2017:851.
    [18]
    Cui F,Woodring J,Chan P,et al. Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China[J]. Int J Epidemiol,2018,47(5):1529-1537.
    [19]
    Zheng H,Cui F,Wang F,et al. The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China[J]. J Viral Hepat,2018,25(1):88-96.
    [20]
    王智强,纪存委,高爽,等.广东省妇幼保健院门诊孕妇HBV感染状况分析[J].中国妇幼健康研究,2018,29(11):1491-1493.
    [21]
    范小清,陈晓峰,张小央.孕产妇乙肝表面抗原阳性筛查状况分析[J].中国妇幼保健,2020,35(2):227-229.
    [22]
    黎沙,杜进发,钟革,等.广西乙型病毒性肝炎高流行区育龄妇女血清流行病学调查[J].应用预防医学,2018,24(2):108-112.
    [23]
    胡培,邵晓萍,方苓,等.广东省2013年乙型病毒性肝炎高流行区农村育龄妇女血清流行病学调查[J].中国疫苗和免疫,2015,21(4):378-382.
    [24]
    Jing W,Liu J,Liu M. Eliminating mother-to-child transmission of HBV:progress and challenges in China[J]. Front Med,2020,14(1):21-29.
    [25]
    Zou H,Chen Y,Duan Z,et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBs Ag-positive mothers[J]. J Viral Hepat,2012,19(2):e18-e25.
    [26]
    卫生部.卫生部办公厅关于印发《预防艾滋病、梅毒和乙肝母婴传播工作实施方案》的通知[EB/OL].http:∥www. gov. cn/zwgk/2011-02/24/content_1809480. htm. 2011-2-12/2020-3-20.
    [27]
    国家卫生和计划生育委员会妇幼健康服务司,中国疾病预防控制中心妇幼保健中心.《预防艾滋病、梅毒和乙肝母婴传播工作实施方案(2015年版)》解读[J].中国妇幼卫生杂志,2015,6(6):1-2.
    [28]
    云南日报.2010年至2016年云南省174万名育龄夫妇获优生免费检查[EB/OL]. http:∥yn. people.com. cn/n2/2017/0411/c378439-30002639. html. 2017-4-11/2020-3-20.
    [29]
    桂平市卫生健康局.关于印发2019年桂平市免费婚前医学保健和孕前优生健康检查实施方案的通知[EB/OL]. http:∥www. guiping. gov. cn/xxgk/zdlyxxgk/qtlyxx/syfw/20190506-1881375. shtml. 2019-4-30/2020-3-20.
    [30]
    Chamroonkul N,Piratvisuth T. Hepatitis B During Pregnancy in Endemic Areas:Screening, Treatment, and Prevention of Mother-to-Child Transmission[J]. Pediatric Drugs,2017,19(3):173-181.
    [31]
    Amsalu A,Ferede G,Eshetie S,et al. Prevalence,Infectivity,and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital,Ethiopia:Implication of Screening to Control Mother-toChild Transmission[J]. J Pregnancy,2018(2018):1-8.
    [32]
    Terrault Norah A,Lok Anna SF,McMahon Brian J,et al. Update on prevention,diagnosis,and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology(Baltimore,Md.),2018,67(4):1560-1599.
    [33]
    张国虎.抗病毒治疗对高病毒载量乙型肝炎孕妇HBV母婴传播的阻断作用及其安全性探讨[J].中国实用医药,2019,14(17):94-95.
    [34]
    黄群,赵晓明.妊娠中晚期抗病毒治疗在乙肝母婴阻断的疗效观察[J].青海医药杂志,2017,47(7):6-8.
    [35]
    刘玉娟,蔡秋娥,王淼,等.抗病毒治疗在阻断高病毒载量乙肝孕妇母婴传播中的临床效果[J].广东医学,2018,39(16):2483-2484.
    [36]
    梁馨元,肖小敏.产前抗病毒治疗对于阻断乙肝病毒母婴垂直传播作用的Meta分析[J].现代妇产科进展,2016,25(12):911-915.
    [37]
    邱波,朱玲,陈艳,等.妊娠期不同阶段给予替比夫定阻断乙型肝炎病毒宫内母婴传播的研究[J].实用肝脏病杂志,2016,19(4):428-431.
    [38]
    张璐.替诺福韦对乙型肝炎病毒感染孕妇母婴阻断疗效及安全性评价[D].郑州:郑州大学,2019.
    [39]
    Wang M,Bian Q,Zhu Y,et al. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load[J]. Aliment Pharmacol Ther,2019,49(2):211-217.
    [40]
    European Association for the Study of the Liver(EASL).EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection[J]. Journal of Hepatology,2017,67(2):370-398.
    [41]
    Ioannis E,Elena V,Dimitrios V,et al. Post-partum reactivation of chronic hepatitis B virus infection among hepatitis B e-antigen-negative women[J]. World Journal of Gastroenterology,2015,21(4):1261-1267.
    [42]
    马德明,张玉,张丽娜,等.第二产程时长与乙型肝炎病毒产时传播的相关性分析[J].中国妇幼保健,2018,33(14):3156-3158.
    [43]
    吕婧,祁渊,吴琼,等.第三产程不同干预方式在乙肝病毒携带产妇中的应用效果[J].广西医学,2019,41(18):2382-2384.
    [44]
    李璐,邹怀宾,陈煜.乙型肝炎母婴阻断研究进展[J].肝脏,2018,23(7):640-643.
    [45]
    罗灿,汤柳英,王雄虎,等.乙型肝炎病毒母婴传播影响因素的研究进展[J].中国妇幼卫生杂志,2016,7(6):72-75.
    [46]
    国家卫生计生委办公厅.国家卫生计生委办公厅关于全面开展预防艾滋病、梅毒和乙肝母婴传播工作的通知[EB/OL]. http:∥www. nhc. gov. cn/fys/gzbs/201506/4f2123fa955a44afa75a75da2ad35d6e. shtml. 2015-6-16/2020-3-20.
    [47]
    Wei K,Zhu F,Liu J,et al. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus:A prospective cohort study[J]. Vaccine,2017,36(2):256-263.
    [48]
    刘晓霞,杨安华,王晓琼,等.10μg和5μg乙型肝炎疫苗与乙型肝炎免疫球蛋白联合免疫阻断乙型肝炎病毒母婴传播的效果观察[J].中国疫苗和免疫,2018,24(4):393-396.
    [49]
    李杰,卢颖,卫凯平,等.关于进一步完善预防乙型肝炎病毒母婴传播免疫策略的探讨[J].中华肝脏病杂志,2019,27(2):97-101.
    [50]
    WHO. Hepititis B[EB/OL]. https:∥www. who. int/zh/news-room/fact-sheets/detail/hepatitis-b. 2019-7-18/2020-3-20.
    [51]
    马小军,王富珍,郑徽,等.青海省三个地区乙型肝炎病毒表面抗原阳性母亲所生婴儿免疫后血清学检测现状[J].中国疫苗和免疫,2017,23(5):503-507.
    [52]
    郑敏,郑佳瑞,郭光萍,等.2014—2018年云南省孕产妇HIV梅毒和HBV检测结果[J].中国艾滋病性病,2019,25(8):798-801.
    [53]
    于秀平,于滔,王学海,等.2012—2013年吉林省双辽市孕产妇艾滋病梅毒乙肝病毒检测研究[J].中国卫生工程学,2016,15(1):77-78.
    [54]
    覃清华,谢小花,张华,等.2011—2016年广西孕产妇艾滋病、梅毒和乙肝血清学监测分析[J].中国健康教育,2018,34(1):10-13.
    [55]
    Qiao Y,Su M,Song Y,et al. Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China,2016–2017[J]. Infectious Diseases of Poverty,2019,8(1):65.
    [56]
    郑敏,郭光萍,李燕,等.云南省德宏州2014—2018年消除艾滋病、梅毒和乙肝母婴传播效果研究[J].皮肤病与性病,2019,41(3):343-346.
    [57]
    宋瑶,王爱玲,乔亚萍,等.316例乙型肝炎暴露婴幼儿母婴传播发生状况调查[J].中国疫苗和免疫,2018,24(4):397-401.
    [58]
    Zhu Q,Shao X,Chen S,et al. Epidemiological serosurvey of hepatitis B virus among children aged 1-14years in Guangdong Province,China[J]. Int J Infect Dis,2018,71:25-29.
    • Related Articles

  • Cited by

    Periodical cited type(3)

    1. 刘剑峰，李文豪，王娟，邱春红. 2019—2022年深圳市流动与常住孕妇乙型肝炎病毒感染状况的比较分析. 中国妇幼保健. 2025(06): 1069-1073 .
    2. 苏磊静，李德富，陆兆华，庞智东，言京礼，梁晓丽，陈宁. 孕产妇乙型肝炎病毒感染的多因素分析. 应用预防医学. 2024(04): 231-235 .
    3. 林铭镇，陈小霞，庄海天. 2015—2022年福建省泉州市孕产妇乙肝感染情况分析. 中国妇幼卫生杂志. 2023(05): 8-11 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (21) PDF downloads (18) Cited by(3)
    Turn off MathJax
    Article Contents
    Abstract
    References

    Copyright © Editorial Department of CHINESE JOURNAL OF WOMEN AND CHILDREN HEALTH

    Tel：010-62170910  Email：zgfyws@ncwchnhc.org.cn   Address：Editorial Department of CHINESE JOURNAL OF WOMEN AND CHILDREN HEALTH, No. 12, Dahuisi Road, Haidian District, Beijing

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return